Susceptibility of recent Shigella isòlates to mecillinam, ampicillin, tetracycline, chloramphenicol, and cotrimoxazole
The in-vitro susceptibility of 102 recent Shigella isolates was tested to mecillinam, ampicillin, tetracycline, chloramphenicol, and cotrimoxazole. Twenty-four isolates were resistant to ampicillin, 24 to tetracycline, and 23 to chloramphenicol. Whereas only two isolates were resistant to mecillinam...
Gespeichert in:
| Veröffentlicht in: | Journal of antimicrobial chemotherapy 1981-06, Vol.7 (6), p.619-622 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 622 |
|---|---|
| container_issue | 6 |
| container_start_page | 619 |
| container_title | Journal of antimicrobial chemotherapy |
| container_volume | 7 |
| creator | Uwaydah, Marwan Osseiran, Maher |
| description | The in-vitro susceptibility of 102 recent Shigella isolates was tested to mecillinam, ampicillin, tetracycline, chloramphenicol, and cotrimoxazole. Twenty-four isolates were resistant to ampicillin, 24 to tetracycline, and 23 to chloramphenicol. Whereas only two isolates were resistant to mecillinam and three to cotrimoxazole, there were two isolates intermediately susceptible to mecillinam and eleven to cotrimoxazole. |
| doi_str_mv | 10.1093/jac/7.6.619 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73555169</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15313874</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-4894c72fbd7b2c4d038001f01552ecdb20aaf3f7a341b99e85c285c8174edbce3</originalsourceid><addsrcrecordid>eNqFkc2KFDEUhYMoYzu6ci1k5caunqTyV1nK4EyLLS5GQWYTUqlbdsZUpU3SOO1j-Qq-mJFuZuvicjmcjwOHg9BLSlaUaHZxZ92FWsmVpPoRWlAuSdMSTR-jBWFENIoL9hQ9y_mOECKF7M7QmdSq1Zwu0M-bfXawK773wZcDjiNO4GAu-Gbrv0EIFvv853ewBTIuEU_gfAh-ttMS22nnj2qJC5Rk3cFVAUvstiGmam9h9i6Gis4DdrEkP8V7-ysGeI6ejDZkeHH65-jL1bvPl-tm8-n6_eXbTeOYYKXhneZOtWM_qL51fCCsI4SOhArRghv6llg7slFZxmmvNXTCtfU6qjgMvQN2jl4fc3cp_thDLmbytXDtNUPcZ6OYEIJK_V-QCkZZp3gF3xxBl2LOCUazq7VsOhhKzL89TN3DKCNN3aPSr06x-36C4YE9DVD95uj7XOD-wbbpu5GKKWHWX29Nq9e33UZ-MB_ZX8A5mKA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15313874</pqid></control><display><type>article</type><title>Susceptibility of recent Shigella isòlates to mecillinam, ampicillin, tetracycline, chloramphenicol, and cotrimoxazole</title><source>Oxford University Press Journals Digital Archive legacy</source><source>MEDLINE</source><creator>Uwaydah, Marwan ; Osseiran, Maher</creator><creatorcontrib>Uwaydah, Marwan ; Osseiran, Maher</creatorcontrib><description>The in-vitro susceptibility of 102 recent Shigella isolates was tested to mecillinam, ampicillin, tetracycline, chloramphenicol, and cotrimoxazole. Twenty-four isolates were resistant to ampicillin, 24 to tetracycline, and 23 to chloramphenicol. Whereas only two isolates were resistant to mecillinam and three to cotrimoxazole, there were two isolates intermediately susceptible to mecillinam and eleven to cotrimoxazole.</description><identifier>ISSN: 0305-7453</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/7.6.619</identifier><identifier>PMID: 6972941</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Amdinocillin - pharmacology ; Anti-Bacterial Agents - pharmacology ; Chloramphenicol - pharmacology ; Drug Combinations - pharmacology ; Humans ; Microbial Sensitivity Tests ; Penicillin Resistance ; Shigella ; Shigella - drug effects ; Sulfamethoxazole - pharmacology ; Tetracycline - pharmacology ; Trimethoprim - pharmacology ; Trimethoprim, Sulfamethoxazole Drug Combination</subject><ispartof>Journal of antimicrobial chemotherapy, 1981-06, Vol.7 (6), p.619-622</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-4894c72fbd7b2c4d038001f01552ecdb20aaf3f7a341b99e85c285c8174edbce3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6972941$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Uwaydah, Marwan</creatorcontrib><creatorcontrib>Osseiran, Maher</creatorcontrib><title>Susceptibility of recent Shigella isòlates to mecillinam, ampicillin, tetracycline, chloramphenicol, and cotrimoxazole</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J Antimicrob Chemother</addtitle><description>The in-vitro susceptibility of 102 recent Shigella isolates was tested to mecillinam, ampicillin, tetracycline, chloramphenicol, and cotrimoxazole. Twenty-four isolates were resistant to ampicillin, 24 to tetracycline, and 23 to chloramphenicol. Whereas only two isolates were resistant to mecillinam and three to cotrimoxazole, there were two isolates intermediately susceptible to mecillinam and eleven to cotrimoxazole.</description><subject>Amdinocillin - pharmacology</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Chloramphenicol - pharmacology</subject><subject>Drug Combinations - pharmacology</subject><subject>Humans</subject><subject>Microbial Sensitivity Tests</subject><subject>Penicillin Resistance</subject><subject>Shigella</subject><subject>Shigella - drug effects</subject><subject>Sulfamethoxazole - pharmacology</subject><subject>Tetracycline - pharmacology</subject><subject>Trimethoprim - pharmacology</subject><subject>Trimethoprim, Sulfamethoxazole Drug Combination</subject><issn>0305-7453</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1981</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc2KFDEUhYMoYzu6ci1k5caunqTyV1nK4EyLLS5GQWYTUqlbdsZUpU3SOO1j-Qq-mJFuZuvicjmcjwOHg9BLSlaUaHZxZ92FWsmVpPoRWlAuSdMSTR-jBWFENIoL9hQ9y_mOECKF7M7QmdSq1Zwu0M-bfXawK773wZcDjiNO4GAu-Gbrv0EIFvv853ewBTIuEU_gfAh-ttMS22nnj2qJC5Rk3cFVAUvstiGmam9h9i6Gis4DdrEkP8V7-ysGeI6ejDZkeHH65-jL1bvPl-tm8-n6_eXbTeOYYKXhneZOtWM_qL51fCCsI4SOhArRghv6llg7slFZxmmvNXTCtfU6qjgMvQN2jl4fc3cp_thDLmbytXDtNUPcZ6OYEIJK_V-QCkZZp3gF3xxBl2LOCUazq7VsOhhKzL89TN3DKCNN3aPSr06x-36C4YE9DVD95uj7XOD-wbbpu5GKKWHWX29Nq9e33UZ-MB_ZX8A5mKA</recordid><startdate>198106</startdate><enddate>198106</enddate><creator>Uwaydah, Marwan</creator><creator>Osseiran, Maher</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>198106</creationdate><title>Susceptibility of recent Shigella isòlates to mecillinam, ampicillin, tetracycline, chloramphenicol, and cotrimoxazole</title><author>Uwaydah, Marwan ; Osseiran, Maher</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-4894c72fbd7b2c4d038001f01552ecdb20aaf3f7a341b99e85c285c8174edbce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1981</creationdate><topic>Amdinocillin - pharmacology</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Chloramphenicol - pharmacology</topic><topic>Drug Combinations - pharmacology</topic><topic>Humans</topic><topic>Microbial Sensitivity Tests</topic><topic>Penicillin Resistance</topic><topic>Shigella</topic><topic>Shigella - drug effects</topic><topic>Sulfamethoxazole - pharmacology</topic><topic>Tetracycline - pharmacology</topic><topic>Trimethoprim - pharmacology</topic><topic>Trimethoprim, Sulfamethoxazole Drug Combination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uwaydah, Marwan</creatorcontrib><creatorcontrib>Osseiran, Maher</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uwaydah, Marwan</au><au>Osseiran, Maher</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Susceptibility of recent Shigella isòlates to mecillinam, ampicillin, tetracycline, chloramphenicol, and cotrimoxazole</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J Antimicrob Chemother</addtitle><date>1981-06</date><risdate>1981</risdate><volume>7</volume><issue>6</issue><spage>619</spage><epage>622</epage><pages>619-622</pages><issn>0305-7453</issn><eissn>1460-2091</eissn><abstract>The in-vitro susceptibility of 102 recent Shigella isolates was tested to mecillinam, ampicillin, tetracycline, chloramphenicol, and cotrimoxazole. Twenty-four isolates were resistant to ampicillin, 24 to tetracycline, and 23 to chloramphenicol. Whereas only two isolates were resistant to mecillinam and three to cotrimoxazole, there were two isolates intermediately susceptible to mecillinam and eleven to cotrimoxazole.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>6972941</pmid><doi>10.1093/jac/7.6.619</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0305-7453 |
| ispartof | Journal of antimicrobial chemotherapy, 1981-06, Vol.7 (6), p.619-622 |
| issn | 0305-7453 1460-2091 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_73555169 |
| source | Oxford University Press Journals Digital Archive legacy; MEDLINE |
| subjects | Amdinocillin - pharmacology Anti-Bacterial Agents - pharmacology Chloramphenicol - pharmacology Drug Combinations - pharmacology Humans Microbial Sensitivity Tests Penicillin Resistance Shigella Shigella - drug effects Sulfamethoxazole - pharmacology Tetracycline - pharmacology Trimethoprim - pharmacology Trimethoprim, Sulfamethoxazole Drug Combination |
| title | Susceptibility of recent Shigella isòlates to mecillinam, ampicillin, tetracycline, chloramphenicol, and cotrimoxazole |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T02%3A17%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Susceptibility%20of%20recent%20Shigella%20is%C3%B2lates%20to%20mecillinam,%20ampicillin,%20tetracycline,%20chloramphenicol,%20and%20cotrimoxazole&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=Uwaydah,%20Marwan&rft.date=1981-06&rft.volume=7&rft.issue=6&rft.spage=619&rft.epage=622&rft.pages=619-622&rft.issn=0305-7453&rft.eissn=1460-2091&rft_id=info:doi/10.1093/jac/7.6.619&rft_dat=%3Cproquest_cross%3E15313874%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15313874&rft_id=info:pmid/6972941&rfr_iscdi=true |